Lorpucitinib
CAS No. 2230282-02-5
Lorpucitinib( —— )
Catalog No. M35614 CAS No. 2230282-02-5
Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 543 | In Stock |
|
| 10MG | 867 | In Stock |
|
| 25MG | 1644 | In Stock |
|
| 50MG | 2595 | In Stock |
|
| 100MG | 3506 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLorpucitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
-
DescriptionLorpucitinib is a Gut-Restricted JAK Inhibitor for the research of Inflammatory Bowel Disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230282-02-5
-
Formula Weight408.5
-
Molecular FormulaC22H28N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (612.00 mM; Ultrasonic )
-
SMILESCC(C)(O)CNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Leonard KA, Madge LA, Krawczuk PJ, Wang A, Kreutter KD, Bacani GM, Chai W, Smith RC, Tichenor MS, Harris MC, Malaviya R, Seierstad M, Johnson ME, Venable JD, Kim S, Hirst GC, Mathur AS, Rao TS, Edwards JP, Rizzolio MC, Koudriakova T. Discovery of a Gut-Re?
molnova catalog
related products
-
AG-490
AG-490 (Tyrphostin AG 490) is a multi-targeted tyrphostin family of tyrosine kinase inhibitor.
-
LY2784544
LY2784544 (Gandotinib) is a potent, selective and ATP-competitive inhibitor of JAK2V617F.
-
Fedratinib hydrochlo...
Fedratinib hydrochloride hydrate is a potent, selective, ATP-competitive and orally active JAK2 inhibitor.
Cart
sales@molnova.com